Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAiq Limited Regulatory News (AIQ)

Share Price Information for Aiq Limited (AIQ)

Share Price is delayed by 15 minutes
Get Live Data
6.50    0.00 (0.00%)
Bid:
5.00
Ask:
8.00
Spread: 3.00 (60.00%)
Market Cap: £4.21m
AIQ Live PriceLast checked at - London Stock Exchange

Intraday Aiq Limited Share Chart

Potential Acquisition and Suspension of Listing

16 Sep 2019 07:35

RNS Number : 4125M
AIQ Limited
16 September 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN.

This announcement contains information which, prior to its disclosure, was inside information for the purpose of the Market Abuse Regulation.

For Immediate Release

16 September 2019

AIQ Limited

("AIQ" or the "Company")

Potential Acquisition and Suspension of Listing and Trading

AIQ Limited (LSE: AIQ), a special purpose acquisition company formed to undertake one or more acquisitions of a target company or business in the e-commerce sector, is pleased to announce that it has signed heads of terms to acquire the entire issued share capital of Alchemist Codes Sdn. Bhd. ("Alchemist" or "Al Codes").

Alchemist

Alchemist is a Malaysian incorporated information technology solutions developer for the e-commerce sector. Alchemist has two primary lines of business: an IT consultancy business, which engages in online app development for clients, and an e-commerce app, OCTAPLUS, which leverages proprietary data analytic tools, including artificial intelligence technology, for user targeting. Alchemist's key customer regions are currently Malaysia, Singapore and Hong Kong, with expansion plans to grow into China and Europe.

The Acquisition

Following recent discussions, the Company has entered into conditional, non-binding heads of terms with Alchemist for the acquisition of the entire issued share capital of Alchemist for a consideration of approximately £2.3 million ("Potential Acquisition") to be satisfied through the issue of new ordinary shares of 1p each in the Company ("Ordinary Shares").

The Potential Acquisition is conditional upon, among other things, the completion of satisfactory due diligence, the negotiation and the entry into of legal documentation, any requisite third party consents being obtained and the readmission of the Company's enlarged share capital to the Standard Listing segment of the Official List of the Financial Conduct Authority (the "FCA"), and return to trading of the Ordinary Shares (existing and new) on the London Stock Exchange's (the "LSE") Main Market for listed securities.

Suspension of Ordinary Shares

Due to the nature of the Potential Acquisition, it will constitute a reverse takeover under the FCA's Listing Rules since, inter alia, in substance it will result in a fundamental change in the business of the Company. As a consequence, the Company has requested the suspension of the listing in the Ordinary Shares on the Standard Listing segment of the Official List of the FCA, and trading in the Ordinary Shares on the LSE's Main Market for listed securities will be suspended with effect from 7.30 a.m. (UK time) today, until the Company publishes a prospectus in relation to the Potential Acquisition or it being announced that the Potential Acquisition will not proceed.

As the Potential Acquisition will be a reverse takeover under the Listing Rules, on completion of the Potential Acquisition, the listing on the Standard Listing segment of the Official List of all existing Ordinary Shares will be cancelled. Application will need to be made to the FCA and the LSE for the immediate readmission of the Ordinary Shares, including the new shares issued as consideration for Alchemist, to the Standard Listing segment of the Official List and to trading on the LSE's Main Market for listed securities.

Further announcements will be made, as appropriate, in due course.

**ENDS**

Enquiries

AIQ Limited

+44 (0)14 9162 8376

Graham Duncan, Chairman

 

 

 

VSA Capital Limited (Financial Adviser & Corporate Broker)

+44 (0)20 3005 5000

Andrew Raca, James Deathe

 

 

 

Luther Pendragon (Media Relations)

+44 (0)20 7618 9100

Claire Norbury, Rachel So

 

 

This announcement contains information which, prior to its disclosure, was inside information for the purpose of the Market Abuse Regulation

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGUCPBUPBUQQ
Date   Source Headline
8th May 20267:00 amRNSDirectorate Change
28th Apr 202612:24 pmRNSResult of AGM
1st Apr 20267:00 amRNSNotice of AGM
31st Mar 20263:41 pmRNSLoan Agreement
26th Feb 20267:00 amRNSFinal Results and Publication of Annual Report
16th Feb 20267:00 amRNSStatement re. Convertible Loan Note Facility
5th Feb 202611:55 amRNSLoan Agreement
7th Oct 20259:52 amRNSLoan Agreement
30th Jul 202510:31 amRNSInterim Results
18th Jul 202510:41 amRNSLoan Agreement
6th May 20257:00 amRNS-RStrategic partnership with Centslink
22nd Apr 20253:12 pmRNSResult of AGM
4th Apr 202510:25 amRNSLoan Agreement
28th Mar 20255:08 pmRNSNotice of AGM
26th Feb 20257:00 amRNSFinal Results and Publication of Annual Report
24th Feb 20257:00 amRNSStatement re. Convertible Loan Note Facility
28th Jan 20254:29 pmRNSLoan Agreement
11th Nov 202411:37 amRNSLoan Agreement
26th Sep 20247:00 amRNSLoan Agreement
29th Jul 20247:00 amRNSInterim Results
5th Jul 20247:41 amRNSLoan Agreement
4th Jun 20241:43 pmRNSDirector Declaration
23rd Apr 202410:17 amRNSResult of AGM
25th Mar 20244:00 pmRNSNotice of AGM
28th Feb 20247:00 amRNSFinal Results and Publication of Annual Report
31st Jul 20237:00 amRNSStatement re. Convertible Loan Note Facility
31st Jul 20237:00 amRNSInterim Results
18th Apr 202311:20 amRNSResult of Annual General Meeting
27th Mar 20237:00 amRNSNew Contract
20th Mar 20237:00 amRNSNotice of AGM
28th Feb 20231:50 pmRNSFinal Results and Publication of Annual Report
24th Feb 20231:28 pmRNSChange of Auditor
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
6th Oct 202211:05 amRNSSecond Price Monitoring Extn
6th Oct 202211:00 amRNSPrice Monitoring Extension
6th Oct 20227:00 amRNSDirectorate Change
3rd Oct 202212:15 pmRNSAppointment of Financial Adviser
1st Aug 202211:06 amRNSSecond Price Monitoring Extn
1st Aug 202211:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSInterim Results
14th Apr 202210:46 amRNSResult of AGM
22nd Mar 20227:00 amRNSNew contract and partnerships for NFT marketplace
17th Mar 20227:00 amRNSNotice of AGM
28th Feb 20223:17 pmRNSFinal Results and Publication of Annual Report
28th Feb 20227:00 amRNSFinal Results and Publication of Annual Report
25th Jan 202210:13 amRNSIssue of Convertible Loan Notes to raise £500,000
29th Nov 20212:06 pmRNSSecond Price Monitoring Extn
29th Nov 20212:00 pmRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.